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Incidental Detections Suggestive of COVID-19 in Asymptomatic Patients Undergoing
68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT Scan for Oncological Indications
COVID-19 Zufallsbefund bei asymptomatischen Patienten mit 68Ga-DOTATATE
und 68Ga-PSMA-11 PET-CT-Untersuchung aufgrund onkologischer Indikation
Introduction
A novel severe acute respiratory syndrome
coronavirus 2, SARS-CoV-2, has emerged
in China in December 2019, resulting in
an atypical pneumonia called Corona Virus
Disease 2019 (COVID-19). The disease has
continued to extend globally as the first
21st century pandemic [1]. Despite the
suboptimal sensitivity of polymerase chain
reaction (RT-PCR) assay, it has been widely
considered as the gold standard of diagno-
sis in the early stages of SARS-CoV-2 infec-
tion. Chest computed tomography has
been employed in many countries as a
substitute or complementary tool for
screening/diagnosis, assessment of sever-
ity of the disease, and monitoring of
response to treatment of COVID-19 pneu-
monia. It provides higher sensitivity com-
pared to RT-PCR (98 % versus 71 %). In
many patients, COVID-19 may present
with non-specific respirator and/or consti-
tutional symptoms, such as fever, cough,
and dyspnea, while in some others, may
remain completely asymptomatic [2–7].
Recently, it has been a growing number
of publications about the role of 18F-FDG
PET scan as a non-invasive tool [8, 9]. The
importance of these incidental findings is
mainly because these patients constitute
a more susceptible population to the dis-
ease complications (such as ICU admis-
sion, need for intubation, and death) due
to their underlying conditions, such as
cancer [10, 11]. In these cases, PET/CT
may show increased FDG uptake in med-
iastinal lymph nodes and mild uptake in
lung parenchyma with observation of mul-
tilobar multifocal ground-glass opacities in
the CT portion of the exam. In an acute
chest infection, such as COVID-19, inflam-
matory cells are activated, resulting in re-
lease of local inflammatory chemokines.
Accordingly, activated neutrophils, which
depend on glycolysis, infiltrate into the
lung parenchyma, which manifest as high
FDG uptake on PET/CT. Previous studies
confirmed that increased FDG uptake in
mediastinal and axillary lymph nodes
is associated with increased monocytes
infiltration as the main response of lym-
phoid tissue to scrim viral infections [12].
Several groups reported incidental finding
of COVID-19 in asymptomatic patients
undergoing 18F-FDG PET/CT and 131I
SPECT/CT scans for oncological indications
[2, 8, 13]. Based on these observations,
nuclear medicine physician and nuclear
radiologists should be familiar with the
imaging features of the disease. Under-
standing the imaging findings of COVID-
19 and other pulmonary infections is cru-
cial to ensure appropriate and timely diag-
nosis.
Here, we report 68Ga-DOTATATE and
68Ga-PSMA-11 PET-CT imaging findings
of two asymptomatic coronavirus infec-
tion patients who were admitted to our
nuclear medicine department for oncolo-
gical indications, resulting in incidental




A four-year-old girl with severe hypoglyce-
mia presented to our nuclear medicine
department for 68Ga-DOTATATE PET/CT to
▶ Fig. 1 68Ga-DOTATAE PET/CTscan was performed, which demonstrated bilateral peripheral
dependent ground glass opacities with superimposed consolidations. Increased radiotracer
uptake (SUVmax = 2.45) was also noted, highly suspicious for COVID-19.
Case Report




















































exclude possible pancreatic neuroendo-
crine tumor. Firstly, she underwent abdom-
inal-pelvic CT scan which was negative for
any abnormality. Laboratory testing re-
vealed a white blood cell (WBC) count
within the reference range (6.3 1000/µL)
and also a normal range of serum Crea-
tinine (0.7 mg/dL, reference range 0.6–
1.3mg/dL). Intravenous dose of 51.8MBq
(1.4 mCi) 68Ga-DOTATATE was injected
and after 1 hour the 68Ga-DOTATATE PET/
CT scan was performed using an integrated
6-slice PET/CT scanner. The study revealed
no nodal uptake in the mediastinum, but
multiple peripheral ground-glass opacities
(SUVmax = 2.45) were identified, highly
concerning for COVID-19 (▶ Fig. 1). RT-
PCR for COVID-19 was positive as well
as the serology test detected SARS-CoV-2
IgG and SARS-CoV-2 IgM were positive
(13.5 and 1.7 IU/mL respectively).
Case 2
A 81-year-old man with relapsed prostate
cancer, status post androgen deprivation
therapy (ADT), presented to our nuclear
medicine department. Laboratory testing
showed PSA = 240 ng/mL and white blood
cell (WBC) count within the reference
range (10.10 1000/µL) and a low elevation
of Creatinine (1.8mg/dL, reference range
0.6–1.3mg/dL). Additionally, the number
of platelets was decreased to 125 1000/µL
(reference range 140–450 1000/µL). A
high-resolution chest computed tomog-
raphy (HR-CT) was previously performed,
which revealed a soft tissue density
non-calcified right peripheral pulmonary
nodule with irregular borders (9 mm in
diameter). Scattered smaller soft tissue
density pulmonary nodules of 3 to 4mm
in diameter were also identified involving
bilateral lungs. The bone scintigraphy was
negative for metastatic osseous disease. At
our institution, an intravenous dose of
181.3MBq (4.9 mCi) 68Ga-PSMA-11 was
injected. After 1 hour, imaging was per-
formed on an integrated 6-slice PET/CT
scanner, with scanning from the skull top
to the mid-thigh.
The 68Ga-PSMA-11 PET/CTscan revealed
a right supraclavicular lymph node with in-
creased PSMA uptake (SUVmax = 8.91).
Multiple mediastinal lymph nodes were
noticed in the right upper paratracheal,
subcarinal, retroesophageal, and left para-
tracheal compartments. A soft tissue den-
sity non-calcified right upper lobe pulmo-
nary nodule with increased tracer uptake
(SUVmax=5.42), left upper lobe pulmonary
nodule (posterior segment) with increased
tracer uptake (SUVmax = 4.17), as well as
another small right hilar pulmonary nodule
(SUVmax=6.53) were identified. Also inter-
lobular septal thickening showing increased
activity (SUVmax = 6.53). Incidentally, bilat-
eral ground-glass opacities were noted
involving bilateral lungs with mildly in-
creased PSMA uptake, highly concerning for
COVID-19. However, initial SARS-CoV-2
RT-PCR was negative (▶ Fig. 2).
Discussion
There have been several reports in recent
literature regarding incidental detection
of COVID-19 on 18F-FDG PET/CT scans.
Although no role for diagnosis of SARS-
CoV-2 infection by PET/CT can be consid-
ered, the incidental finding of the disease
on PET/CT imaging can have a significant
effect on the patient management and
should be reported carefully. In fact, the in-
terpretation of PET/CT studies should not
be limited to the evaluation of oncologic
findings. With the increasing number of
the SARS-CoV-2 infection worldwide,
interpreting radiologist and nuclear medi-
cine physicians should be completely train-
ed and aware of the imaging features of
COVID-19 pneumonia. More specifically,
constant vigilance is required to include
COVID-19 in the differential diagnosis in
patients with suspicious imaging features.
PET has shed light particularly at early and
non-specific stages of the disease with chal-
lenging clinical symptoms [8–11, 13, 14].
In our case report, we described 68Ga-
DOTATATE and 68Ga-PSMA-11 imaging of
two patients with asymptomatic COVID-19.
The role of these two radiotracers in the di-
agnosis, post-treatment follow-up, and
management of neuroendocrine and pros-
tate malignancies is well known. We strong-
ly recommend the evaluation of PET/CT
images for non-oncologic conditions in daily
practice of radiology and nuclear medicine,
as this may lead to timely detection of cru-
cial non-oncologic pathologies of high clini-
cal importance in patient management.
These days, extremely high clinical index of
suspicion for COVID-19 and low threshold
for paraclinical screening and diagnostic
testing of SARS-CoV-2 infection, such as
PCR and CT chest, allows earlier diagnosis
and treatment of this potentially life-threa-
tening condition. Timely detection of the
▶ Fig. 2 68Ga-PSMA-11 scan performed for an 81-year-old man suspected to have pulmonary
metastases of prostate cancer. The 68Ga-PSMA-11 PET/CT scan revealed bilateral ground-glass
opacities and consolidations with mildly increased PSMA uptake, concerning for COVID-19.



















































disease by the interpreting radiologist also
can help ensure appropriate post-exposure
precautions in nuclear medicine depart-
ments are implemented and the staff and
other patients are protected.
Conflict of Interest
The authors declare that they have no con-
flict of interest.
Authors
Habibollah Dadgar1, Nasim Norouzbeigi1,
Ali Gholamrezanezhad2, Majid Assadi3
1 The Cancer Research Center, Razavi Hospital,
Imam Reza International University, Mashhad,
Iran
2 Department of Radiology, Keck School of
Medicine, University of Southern California
(USC), 1500 San Pablo Street, Los Angeles,
CA 90033 USA
3 The Persian Gulf Nuclear Medicine Research
Center, Department of Molecular Imaging and
Radionuclide Therapy, Bushehr Medical
University Hospital, Bushehr University of
Medical Sciences, Bushehr, Iran
Correspondence
Prof. Majid Assadi
The Persian Gulf Nuclear Medicine Research
Center, Department of Molecular Imaging
and Radionuclide Therapy, Bushehr Medical






[1] Lütje S, Marinova M, Kütting D et al. Nuclear
medicine in SARS-CoV-2 pandemia: 18F-FDG-
PET/CT to visualize COVID-19. Nuklear-
medizin 2020; 59 (3): 276–280. English.
doi:10.1055/a-1152-2341. Epub 2020 Apr 7.
PMID: 32259853
[2] Albano D, Bertagna F, Bertoli M et al. Inci-
dental Findings Suggestive of COVID-19 in
Asymptomatic Patients Undergoing Nuclear
Medicine Procedures in a High-Prevalence
Region. J Nucl Med 2020; 61 (5): 632–636.
doi:10.2967/jnumed.120.246256. Epub 2020
Apr 1. PMID: 32238429
[3] Huang C, Wang Y, Li X et al. Clinical features of
patients infected with 2019 novel coronavirus in
Wuhan, China. Lancet 2020; 395 (10223): 497–
506. doi:10.1016/S0140-6736(20)30183-5.
Epub 2020 Jan 24. Erratum in: Lancet. 2020
Jan 30. PMID: 31986264; PMCID: PMC7159299
[4] Shi H, Han X, Jiang N et al. Radiological find-
ings from 81 patients with COVID-19 pneu-
monia in Wuhan, China: a descriptive study.
Lancet Infect Dis 2020; 20 (4): 425–434.
doi:10.1016/S1473-3099(20)30086-4.
Epub 2020 Feb 24. PMID: 32105637;
PMCID: PMC7159053
[5] Li G, Li W, He X et al. Asymptomatic and
Presymptomatic Infectors: Hidden Sources
of Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis 2020; 71 (8): 2018.
doi:10.1093/cid/ciaa418. PMID: 32271372;
PMCID: PMC7184467
[6] Assadi M, Gholamrezanezhad A, Jokar N et al.
Key elements of preparedness for pandemic
coronavirus disease 2019 (COVID-19) in
nuclear medicine units. Eur J Nucl Med
Mol Imaging 2020; 47 (8): 1779–1786.
doi:10.1007/s00259-020-04780-4.
PMID: 32318782; PMCID: PMC7171056
[7] Salehi S, Abedi A, Balakrishnan S et al. Coro-
navirus disease 2019 (COVID-19) imaging
reporting and data system (COVID-RADS)
and common lexicon: a proposal based on the
imaging data of 37 studies. Eur Radiol 2020;
30 (9): 4930–4942. doi:10.1007/s00330-
020-06863-0. Epub 2020 Apr 28.
PMID: 32346790; PMCID: PMC7186323
[8] Qin C, Liu F, Yen TC et al. 18F-FDG PET/CT
findings of COVID-19: a series of four highly
suspected cases. Eur J Nucl Med Mol Imaging
2020; 47 (5): 1281–1286. doi:10.1007/
s00259-020-04734-w. Epub 2020 Feb 22.
PMID: 32088847; PMCID: PMC7080035
[9] Deng Y, Lei L, Chen Y et al. The potential
added value of FDG PET/CT for COVID-19
pneumonia. Eur J Nucl Med Mol Imaging
2020; 47 (7): 1634–1635. doi:10.1007/
s00259-020-04767-1. Epub 2020 Mar 21.
PMID: 32198615; PMCID: PMC7087529
[10] Alberts I, Vollnberg B, Sachpekidis C et al.
Incidental SARS-CoV-2-related findings in
asymptomatic patients in [18F]-FDG-PET/
CT-potential insights. Eur J Nucl Med Mol
Imaging 2020; 47 (9): 2068–2069.
doi:10.1007/s00259-020-04869-w.
Epub 2020 May 22. PMID: 32444898;
PMCID: PMC7244259
[11] Kooraki S, Hosseiny M, Myers L et al. Coro-
navirus (COVID-19) Outbreak: What the
Department of Radiology Should Know.
J Am Coll Radiol 2020; 17 (4): 447–451.
doi:10.1016/j.jacr.2020.02.008. Epub 2020
Feb 19. PMID: 32092296; PMCID:
PMC7102595
[12] Chefer S, Thomasson D, Seidel J et al. Mod-
eling [(18)F]-FDG lymphoid tissue kinetics
to characterize nonhuman primate immune
response to Middle East respiratory syn-
drome-coronavirus aerosol challenge.
EJNMMI Res 2015; 5 (1): 65. doi:10.1186/
s13550-015-0143-x. Epub 2015 Nov 16.
PMID: 26573211; PMCID: PMC4646887
[13] Martineau P, Kidane B. FDG PET/CT Findings
in an Asymptomatic Case of Confirmed
COVID-19. Clin Nucl Med 2020; 45 (8): 647–
648. doi:10.1097/RLU.0000000000003145.
PMID: 32433160; PMCID: PMC7268853
[14] Playe M, Siavellis J, Braun T et al. FDG PET/CT
in a Patient With Mantle Cell Lymphoma and
COVID-19: Typical Findings. Clin Nucl Med




Nuklearmedizin 2021; 60: 106–108
Published online: December 16, 2020
DOI 10.1055/a-1311-2856
ISSN 0029-5566
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG, Rüdigerstraße 14,
70469 Stuttgart, Germany
108 Dadgar H et al. Incidental Detections Suggestive… Nuklearmedizin 2021; 60: 106–108 | © 2020. Thieme. All rights reserved.
Case Report
T
hi
s 
do
cu
m
en
t w
as
 d
ow
nl
oa
de
d 
fo
r 
pe
rs
on
al
 u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
is
tr
ib
ut
io
n 
is
 s
tr
ic
tly
 p
ro
hi
bi
te
d.
